Burden of chronic diseases among sarcoma survivors treated with anthracycline chemotherapy: results from an observational study

por Baker, Laurence H., Boonstra, Philip S., Reinke, Denise K., Antalis, Erin J. Peregrine, Zebrack, Bradley J., Weinberg, Richard L.
Publicado 2020

Circulating Tumor DNA Is Associated with Response and Survival in Patients with Advanced Leiomyosarcoma

por Madanat-Harjuoja, Laura M., Klega, Kelly, Lu, Yao, Shulman, David S., Thorner, Aaron R., Nag, Anwesha, Tap, William D., Reinke, Denise K., Diller, Lisa, Ballman, Karla V., George, Suzanne, Crompton, Brian D.
Publicado 2022

AI-Radiomics Can Improve Inclusion Criteria and Clinical Trial Performance

por Tomaszewski, Michal R., Fan, Shuxuan, Garcia, Alberto, Qi, Jin, Kim, Youngchul, Gatenby, Robert A., Schabath, Matthew B., Tap, William D., Reinke, Denise K., Makanji, Rikesh J., Reed, Damon R., Gillies, Robert J.
Publicado 2022

A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results

por Attia, Steven, Bolejack, Vanessa, Ganjoo, Kristen N., George, Suzanne, Agulnik, Mark, Rushing, Daniel, Loggers, Elizabeth T., Livingston, Michael B., Wright, Jennifer, Chawla, Sant P., Okuno, Scott H., Reinke, Denise K., Riedel, Richard F., Davis, Lara E., Ryan, Christopher W., Maki, Robert G.
Publicado 2022

A Randomized, Double‐Blind, Placebo‐Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment‐Refractory Liposarcoma: Results from the SARC024 Stud...

por Riedel, Richard F., Ballman, Karla V., Lu, Yao, Attia, Steven, Loggers, Elizabeth T., Ganjoo, Kristen N., Livingston, Michael B., Chow, Warren, Wright, Jennifer, Ward, John H., Rushing, Daniel, Okuno, Scott H., Reed, Damon R., Liebner, David A., Keedy, Vicki L., Mascarenhas, Leo, Davis, Lara E., Ryan, Christopher, Reinke, Denise K., Maki, Robert G.
Publicado 2020